International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Cites (261)

Items 201–261 of 261

1. Fusion driven JMML: a novel CCDC88C–FLT3 fusion responsive to sorafenib identified by RNA sequencing
   Alexander K. Chao, Julia A. Meyer, Alex G. Lee et al. · 2019 · Leukemia
2. Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study
   Kathryn Foucar, Eric D. Hsi, Sa A. Wang et al. · 2020 · International Journal of Laboratory Hematology
3. Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition
   JinJuan Yao, Lianrong Xu, Umut Aypar et al. · 2020 · Haematologica
4. Blast and accelerated phase CML: room for improvement
   Joan How, Vinayak Venkataraman, Gabriela Soriano Hobbs · 2021 · Hematology
5. Concurrent CDX2 cis -deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
   Marie Passet, Rathana Kim, Stéphanie Gachet, François Sigaux, Julie Chaumeil, Ava Galland, Tom Sexton, Samuel Quentin, Lucie Hernandez, Lise Larcher et al. · 2022 · Blood
6. Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases
   Carlo Zaninetti, Valeria Santini, Maria Tiniakou · 2017 · Journal of Thrombosis and Haemostasis
7. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study*
   Sabine Käyser, Robert Kerrin Hills, Ralitsa Langova, Michael Krämer, Francesca Guijarro, Zuzana Šustková, Elihu H. Estey, Carole M. Shaw, Zdeněk Ráčil, Jiřı́ Mayer et al. · 2021 · British Journal of Haematology
8. Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification
   Daisuke Hasegawa, Xiaojuan Chen, Shinsuke Hirabayashi et al. · 2014 · British Journal of Haematology
9. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case
   Simone Heiss, Martin Erdel, Eberhard Gunsilius · 2005 · Human Pathology
10. High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood
    Ayami Yoshimi, Charlotte Marie Niemeyer, Irith Baumann · 2012 · British Journal of Haematology
11. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders
    Katalin Kelemen, Leonie Saft, Fiona E. Craig et al. · 2020 · American Journal of Clinical Pathology
12. Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
    Tiziano Barbui, Valerio De Stefano, Anna Falanga, Guido Finazzi, Ida Martinelli, Francesco Rodeghiero, Alessandro Maria Vannucchi, Giovanni Barosi · 2019 · Blood Cancer Journal
13. The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations
    Umberto Gianelli, Daniele Cattaneo, Anna Bossi, Ivan Cortinovis, Leonardo Boiocchi, Yen-Chun Liu, Claudia Augello, Arturo Bonometti, Stefano Fiori, Nicola Orofino et al. · 2016 · Modern Pathology
14. Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia
    Xueyan Chen, Megan K. D. Othus, Brent Lee Wood, Roland B. Walter, Pamela Sue Becker, Mary‐Elizabeth M. Percival, Janis L. Abkowitz, Frederick R. Appelbaum, Elihu H. Estey · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
15. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia
    Ya-Hsuan Chang, Chih‐Hsiang Yu, Shiann‐Tarng Jou, Chien‐Yu Lin, Kai‐Hsin Lin, Meng‐Yao Lu, Kang‐Hsi Wu, Hsiu‐Hao Chang, Dong‐Tsamn Lin, Shu‐Wha Lin et al. · 2021 · Scientific Reports
16. Bone Marrow Morphology Associated With Germline RUNX1 Mutations in Patients With Familial Platelet Disorder With Associated Myeloid Malignancy
    Karen M. Chisholm, Christopher Clement Denton, Sioḃán Keel, Amy E. Geddis, Min Xu, Burton Appel, Alan B Cantor, Mark D. Fleming, Akiko Shimamura · 2019 · Pediatric and Developmental Pathology
17. Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
    Lauseker, Michael, Bachl, Katharina, Turkina, Anna, Faber, Edgar, Prejzner, Witold, Olsson‐Strömberg, Ulla, Baccarani, Michele, Lomaia, Elza, Zackova, Daniela, Ossenkoppele, Gert et al. · 2019 · American Journal of Hematology
18. Frequency and prognostic impact of PAX5 p. P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol
    Mareike Jung, Maximilian Schieck, Winfried A. Hofmann et al. · 2020 · Genes Chromosomes and Cancer
19. Predicting early blast transformation in chronic‐phase chronic myeloid leukemia: Is immunophenotyping the missing link?
    Fuad A. El Rassi, John D. Bergsagel, Martha Lucia Arellano · 2014 · Cancer
20. A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?
    Estelle Troadec, Sophie Dobbelstein, Philìppe Bertrand et al. · 2016 · Leukemia
21. A novel class of ZNF384 aberrations in acute leukemia
    Marketa Kubricanova Zaliova, Lucie Winkowska, Jan Stuchlý, Karel Fišer, Petr Tříska, Martina Zwyrtkova, Ondřej Hrušák, Júlia Starková, Lucie Šrámková, Jan Starý et al. · 2021 · Blood Advances
22. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value
    Juliana E. Hidalgo‐Lόpez, Rashmi Kanagal‐Shamanna, Andres Ernesto Quesada et al. · 2018 · Cancer
23. CD3−CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited
    Caroline Carpentier, Liliane Schandené, Laurent Dewispelaere · 2021 · The Journal of Allergy and Clinical Immunology In Practice
24. WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update
    Hans Michael Kvasnicka · 2013 · Current Hematologic Malignancy Reports
25. Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients
    Jordy C.G. van der Zwet, Valentina Cordo’, Kirsten Canté-Barrett, Jules P.P. Meijerink · 2019 · Advances in Biological Regulation
26. Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
    Marketa Kubricanova Zaliova, Eliška Potůčková, J Lukes, Lucie Winkowska, Júlia Starková, Iveta Janotová, Lucie Šrámková, Jan Starý, Jan Zuna, Martin Stanulla et al. · 2020 · Haematologica
27. Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia
    Zhining Chen, Shimin Hu, Sa A. Wang et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
28. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases
    Hong Fang, Mariko Yabe, Xiaohui Zhang et al. · 2021 · Modern Pathology
29. Chronic myelomonocytic leukemia with t(13;14) in a child
    Nick P. Bown, S. M. Yule, Jerome Evans · 1992 · Cancer Genetics and Cytogenetics
30. The current perspective of low-grade myelodysplastic syndrome in children
    Daisuke Hasegawa · 2016 · International Journal of Hematology
31. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia
    Alfred Chung, Yanli Hou, Robert Shigeo Ohgami, Ann Von Gehr, Dianna G. Fisk, Krishna M. Roskin, Xu Li, Linda Gojenola, Charles D. Bangs, Daniel A. Arber et al. · 2017 · Cancer Genetics
32. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
    Kim-Hien T. Dao, Jeffrey W Tyner, Jason R. Gotlib · 2017 · Current Hematologic Malignancy Reports
33. Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance
    Justin Anthony Chen, Yanli Hou, Krishna M. Roskin et al. · 2021 · Blood Advances
34. DNMT3Aovergrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults
    Margaret A. Ferris, Amanda M. Smith, Sharon E. Heath, Eric J. Duncavage, Matthew James Oberley, David R. Freyer, Robert Francis Wynn, Sofia Douzgou, John M. Maris, Anne F. Reilly et al. · 2021 · Blood
35. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution
    Yoshimasa Kamoda, Kiyotaka Izumi, Futoshi Iioka et al. · 2016 · Acta Haematologica
36. Recent advances in understanding chronic myeloid leukemia: where do we stand?
    Rahul Kumar, Daniela S. Krause · 2021 · Faculty Reviews
37. Transient juvenile myelomonocytic leukemia in the setting of PTPN11 mutation and Noonan syndrome with secondary development of monosomy 7
    Katrina O’Halloran, Arthur Kim Ritchey, Miroslav Djokic · 2017 · Pediatric Blood & Cancer
38. Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis
    Elizabeth Michelle Margolskee, Robert Paul Hasserjian, Duane C. Hassane, Wayne Tam, Susan Mathew, Chi Young Ok, Sa A. Wang, Jean S. Oak, Daniel A. Arber, Attilio Orazi · 2017 · American Journal of Clinical Pathology
39. The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS
    Blanca Xicoy, Ana Triguero, Esperanza Such et al. · 2018 · Leukemia Research
40. B‐cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T‐cell precursor acute lymphoblastic leukaemia/lymphoma (ETP‐ALL/LBL) from other subtypes of T‐cell ALL/LBL
    Hong Fang, Wei Wang, Siba El Hussein · 2021 · British Journal of Haematology
41. Clinicopathological characterisation of myeloproliferative neoplasm‐unclassifiable (MPN‐U): a retrospective analysis from a large UK tertiary referral centre
    Paul Deschamps, Mufaddal T. Moonim, Deepti H. Radia et al. · 2021 · British Journal of Haematology
42. Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis ( MDS/MPN‐RS‐T ) and myelodysplastic syndrome with ring sideroblasts ( MDS‐RS )
    Guillermo Montalban Bravo, Rashmi Kanagal‐Shamanna, Faezeh Darbaniyan et al. · 2021 · American Journal of Hematology
43. Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
    Giuseppe Gaetano Loscocco, Giacomo Coltro, Paola Guglielmelli, Alessandro Maria Vannucchi · 2021 · Cells
44. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group
    Rashmi Kanagal‐Shamanna, Attilio Orazi, Robert Paul Hasserjian, Daniel A. Arber, Kaaren K. Reichard, Eric D. Hsi, Adam Bagg, Heesun Joyce Rogers, Julia Turbiner Geyer, Faezeh Darbaniyan et al. · 2021 · Modern Pathology
45. Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan
    Koichi Moriwaki, Atsushi Manabe, Takeshi Taketani · 2014 · International Journal of Hematology
46. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
    Etienne D. Braekeleer, Nathalie Douet‐Guilbert, Audrey Basinko, Clément Bovo, Nadia Guéganic, Marie‐Josée Le Bris, Fréderic Morel, Marc De Braekeleer · 2011 · PubMed
47. Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors
    Wei Xie, Sa A. Wang, Shimin Hu · 2018 · Cancer Genetics
48. Noonan syndrome‐associated myeloproliferative disorder with somatically acquired monosomy 7: impact on clinical decision making
    Mattias Hofmans, Rieke Schröder, Tim Lammens, Christian Flotho, Charlotte Marie Niemeyer, Nadine Van Roy, Wim Decaluwe, Jan Philippé, Barbara De Moerloose · 2019 · British Journal of Haematology
49. A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow
    Hong Fang, Rhett P. Ketterling, Curtis A. Hanson et al. · 2018 · American Journal of Clinical Pathology
50. Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma
    Kui Nie, David Redmond, Kenneth Eng, Taotao Zhang, Shuhua Cheng, Susan Mathew, Olivier Elemento, Wayne Tam · 2020 · Leukemia
51. Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia - do we have to screen?
    Axel Karow, Christian Flotho, Marie Schneider · 2009 · Haematologica
52. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report
    Koping Chang, Jia‐Hau Liu, Shan‐Chi Yu · 2017 · Human Pathology
53. Myelodysplastic syndromes with no somatic mutations detected by next‐generation sequencing display similar features to myelodysplastic syndromes with detectable mutations
    Sa A. Wang, Chi Young Ok, Annette S. Kim, Fabienne McClanahan Lucas, Elizabeth A. Morgan, Beenu Thakral, Sanjay S. Patel, Valentina Nardi, Keyur Patel, Olga K. Weinberg et al. · 2021 · American Journal of Hematology
54. N‐terminus DUX4 ‐immunohistochemistry is a reliable methodology for the diagnosis of DUX4‐fused B‐lymphoblastic leukemia/lymphoma (N‐terminus DUX4 IHC for DUX4 ‐fused B‐ALL )
    Bradford J. Siegele, Anat O Stemmer-Rachamimov, Henrik Lilljebjörn, Thoas Fioretos, Amanda C. Winters, Paola Dal Cin, Amy L. Treece, Alisa Gaskell, Valentina Nardi · 2022 · Genes Chromosomes and Cancer
55. Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia
    Nancy B.J. Arthur, Uday Prakash Kulkarni, Arun Kumar Arunachalam · 2021 · International Journal of Laboratory Hematology
56. Current Management of Chronic Neutrophilic Leukemia
    Natasha Szuber, Ayalew Tefferi · 2021 · Current Treatment Options in Oncology
57. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm
    Oriana Miltiadous, Kseniya Petrova‐Drus, Shipra M. Kaicker, Susan Mathew, Michael Kluk, Julia Turbiner Geyer, Irene Rodriguez-Sanchez, Nancy Bouvier, Giorgio Inghirami, Elliot Stieglitz et al. · 2021 · Blood Advances
58. Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup
    Laura N. Toth, DONALD PHILIP GREEN, Jason D. Peterson, Sophie J. Deharvengt, Francine Blumental De Abreu, Eric Y. Loo · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
59. Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
    Ana Valencia-Martinez, Alessandro Sanna, Erico Masala, Elisa Contini, Alice Brogi, Antonella Gozzini, Valeria Santini · 2017 · Haematologica
60. Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass
    Amy S. Duffield, Jonathan Allen Webster, Bruce Douglas Smith · 2021 · Head and Neck Pathology
61. Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version
    Jiwon Yun, Jung‐Ah Kim, Junseo Park et al. · 2020 · Leukemia & lymphoma/Leukemia and lymphoma